APO-Candesartan 16 mg (2015-05-01)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| KW0445 | - Recalling Firm
- Apotex Inc.
- 150 Signet Drive
- Toronto
- M9L 1T9
- Ontario
- CANADA
- Marketing Authorization Holder
- Apotex Inc.
- 150 Signet Drive
- Toronto
- M9L 1T9
- Ontario
- CANADA
| A. APO-Candesartan 16 mg | Tablet | DIN 02365367 | Candesartan cilexetil 16 mg |
Recalled products
-
APO-Candesartan 16 mg
Apotex initiated recall of one additional lot of APO-Candesartan due to out of specification results during stability testing for CAD-II impurity.